Onderneming Tiziana Life Sciences PLC London S.E.
Aandelen
GB00B28XMY25
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- GBX | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11-02-98 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Matthew Davis
COO | Chief Operating Officer | - | 01-07-22 |
Paul Spencer
IRC | Investor Relations Contact | - | 01-12-22 |
William Clementi
PRN | Corporate Officer/Principal | - | 01-09-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 01-07-20 |
Willy Simon
BRD | Director/Board Member | 72 | 01-11-15 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11-02-98 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 194 612 289 | 63 373 729 ( 32,56 %) | 0 | 32,56 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ACCUSTEM SCIENCES, INC. 11.80% | 1 337 970 | 11.80% | 445 544 $ |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,77% | 49,46 mld. | |
+1,00% | 42,58 mld. | |
+50,01% | 42,49 mld. | |
-5,26% | 29,09 mld. | |
+13,68% | 26,61 mld. | |
-22,99% | 18,64 mld. | |
+8,22% | 13,16 mld. | |
+32,41% | 12,55 mld. | |
+24,01% | 12,1 mld. |
- Beurs
- Aandelen
- Koers TLSA
- Koers
- Onderneming Tiziana Life Sciences PLC